From: Recurrence of autoimmune liver diseases after liver transplantation: clinical aspects
 | PBC | PSC | AIH |
---|---|---|---|
Recurrence rate | 10–35 % | 9–47 % | 20–42 % |
Outcome | No effect | Moderate effect | Mild effect |
Risk factors | Advanced donor age, recipient’s factors Tacrolimus | Steroid-resistant rejection, OKT3 use, cytomegalovirus infection, male recipient gender, intact colon | High-grade inflammation in the native liver, HLA-DR3 haplotype |